Results 221 to 230 of about 4,215,496 (299)

QSPR/QSAR study of antiviral drugs modeled as multigraphs by using TI's and MLR method to treat COVID-19 disease. [PDF]

Sci Rep
P UP, Suresh M, Tolasa FT, Bonyah E.
europepmc   +1 more source

The 2009 H1N1 Swine Flu Pandemic: Reconciling Goals of Patents and Public Health Initiatives [PDF]

, 2010
Kaplan, Michelle
core   +1 more source

'Unusual' HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment. [PDF]

Gut
Vo-Quang E, Pawlotsky JM.
europepmc   +1 more source

Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study. [PDF]

Clin Mol Hepatol
Hur MH, Lee DH, Lee JH, Kim MS, Park J, Shin H, Chung SW, Cho HJ, Park MK, Jang H, Lee YB, Yu SJ, Lee SH, Jung YJ, Kim YJ, Yoon JH.   +15 more
europepmc   +1 more source

Transcriptomics-driven antiviral drug screening identifies ATF6 as a homeostatic regulator of ER stress and innate immunity

Zhenyu Yang, Jing Sun, Yan Zhao, Ruoqing Feng, Yanhong Tang, Shizhong Bu, Yuan He, Qinan Hu, Jincun Zhao, Yuhui Hu   +9 more
openalex   +1 more source

Future destinations: how people cured of hepatitis C using direct acting antiviral drugs progress in a new HCV-free world. A thematic analysis. [PDF]

Harm Reduct J
Donaldson SR, Radley A, Dillon JF.
europepmc   +1 more source

Feline Adenovirus Isolate Shows Silent Nucleotide Alterations, Alternative Receptor/Coreceptor Binding, High Resistance to Disinfectants and Antiviral Drugs, as Well as Immunomodulation. [PDF]

Animals (Basel)
Tarcsai KR, Bányai K, Bali K, Abbas AA, Kövesdi V, Ongrádi J.   +5 more
europepmc   +1 more source

Long-Term Outcomes of Patients with Liver Cirrhosis After Eradication of Chronic Hepatitis C with Direct-Acting Antiviral Drugs (DAAs). [PDF]

J Hepatocell Carcinoma
Salama M, Darwesh N, Elsabaawy MM, Abdelsameea E, Gomaa A, Sabry A.   +5 more
europepmc   +1 more source

Changes in Vascular Endothelial Growth Factor and Development of Hepatocellular Carcinoma in Direct-Acting Antiviral Drugs (DAAs)-Treated Hepatitis C Virus (HCV) Patients. [PDF]

Cureus
Hassan AM, Orabi HH, Abdel-Gawad M, Mohamed O, Sawy SS, Abdelmeguid MM, Bashir MA, Abdelrazzak E, Ead K, Haridy MA.   +9 more
europepmc   +1 more source